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ATP-binding cassette (ABC) transporters constitute one of the largest trans-
membrane protein families found in all kingdoms of life. These ATP-driven
machineries are essential for many physiological processes by regulating the
transport of lipids, sterols, peptides, toxins, nutrients, drugs and ions across
membranes. The common ABC structural core consists of two transmembrane
domains (TMDs), and two nucleotide-binding domains (NBDs), which provide
two ATP-binding sites. The TMDs are assembled to form the substrate translo-
cation pathway, switching from an inward-facing to an outward-facing confor-
mation. These motions are tightly coupled with those of the NBDs, where
ATP-binding and -hydrolysis inducedimerization anddissociation, respectively.
Asymmetric ABC transporters feature specific mutations in one of the two
ATP-binding sites (the degenerate site), resulting in a reduced ATPase activity
compared to the non-mutated site (the consensus site). It has been proposed that
in asymmetric ABC transporters ATP remains bound at the degenerate site,
while ATP-binding and -hydrolysis at the consensus site drive the transport
cycle.
Here, we investigate the effects of ATP-binding and domains’ motions of the
heterodimeric transporter TM287/288 (Hohl et al., Nat. Struct. Mol. Biol.
2012). We have performed molecular dynamics (MD) simulations, for a total
simulation time of ca. 10 microseconds, on the structure of TM287/288 in
different nucleotide-bound states. Our results show that in the absence of
ATP at the consensus site, the simulation systems with and without ATP at
the degenerate site do not completely dissociate at the NBD level, but reach
an intermediate state in which contacts between the NBDs are still observed.
However, the pattern of interactions at the NBD interface depends on the pres-
ence or the absence of the nucleotide at the degenerate site.
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Energy-coupling factor (ECF) transporters compose of a unique subfamily of
the vast ATP-binding cassette (ABC) transporters. Unlike other ABC trans-
porters, the basic architecture of ECF transporters is not symmetric, that their
membrane sections include two structurally unrelated units: an energy-
coupling component EcfT and a substrate-binding component EcfS. The distinc-
tive composition of ECF transporters is likely to associate with a completely
novel transport mechanism. Although several crystal structures of different iso-
lated EcfS have been resolved, the structure of a full ECF transporter complex
was available only very recently. Surprisingly, the EcfS orientation in the full
ECF transporter is almost perpendicular to an ideal orientation should the
EcfS exist as an isolated transmembrane protein. Based on the crystal structures,
it is proposed that the transport mechanism of ECF transporters involves the
reorientation of EcfS in membrane. Starting with the crystal structure of the
folate ECF transporter, we have performed a series of MD simulations to
evaluate the stability of EcfS with different orientations in membrane, either
isolated or within the full ECF transporter. It is found that the substrate-free
EcfS is able to maintain the membrane-parallel orientation regardless of the
EcfT binding. That is, in addition to the ideal orientation for an isolated EcfS,
the membrane-parallel orientation can be stabilized by the partition of hydro-
philic residues near the membrane surface, as well as the accommodation of
several charged residues near the membrane center by an enclosed lipid head
group in the putative substrate binding site. The tilt angles of the two identified
stable orientations of EcfS differ by ~50 degrees, and the membrane-parallel
form shows slightly higher structural deviations due to repartitioned N- and
C-terminal helices near the membrane surface.
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ABC importers are embedded in the plasma membrane of all bacteria. There
they facilitate the uptake of several vital nutrients and cofactors. Due to differ-
ences in structure and activity, ABC importers are divided into two types. Type
I importers have been well studied, but most of what we know about Type II
importers has been observed in studies of the vitamin B12 importer, BtuC2D2.MolB2C2 (formally known as HI1470/71) is also a Type II importer, but its sub-
strate, molybdate, is about 10x smaller than vitamin B12. To understand mech-
anistic differences among Type II importers, we focused our studies on MolBC
where alternative conformations may be required to transport its relatively
small substrate. To investigate the mechanism of MolBC, we employed elec-
tron paramagnetic resonance (EPR) spectroscopy with the transporter imbed-
ded in detergent micelles and liposomes (spherical lipid bilayers). The use of
both detergent and lipid have allowed us to identify conformational changes
in MolBC and the impact of the lipid environment. We observed that nucleotide
binding and hydrolysis shift the conformation of MolBC at both the cyto-
plasmic and periplasmic gates. Mechanistic differences between MolBC and
other Type II transporters highlight potential effects of substrate size on trans-
port. Combining our results, we propose a mechanism for MolBC-A embedded
in a lipid bilayer, which gives new insight in the transport of small substrates.
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The human genome contains 48 ATP-Binding Cassette (ABC) proteins. We
focus on the multidrug resistance transporter P-glycoprotein that transports an
extraordinarily diverse range of structurally unrelated drugs, xenobiotics and
endogenous substrates. P-glycoprotein is expressed at barrier tissues including
the blood-brain-barrier, the intestine, kidney, liver and macrophages. Cancer
cells acquire resistance to chemotherapy when expressing P-glycoprotein. It is
well established that ATP binding and its subsequent hydrolysis drives the trans-
port process in allABC transporters. In contrast,most details regarding themech-
anism of substrate recognition, uptake and binding to P-glycoprotein, and the
mechanismbywhich substrate binding in the transmembrane domains is coupled
to ATP hydrolysis in the nucleotide binding domains remain unknown.
The bacterial homologue of P-gp, Sav1866 (Staphylococcus aureus), was the
first ABC exporter crystallized. The same fold was later observed in other trans-
porters of the ABCB family, suggesting a conserved architecture across the
ABCB exporter family. Although ABC exporters have now been crystallized
in several conformations, uncertainty remains regarding the physiological
conformation of these structures. None of the crystal structures is fully compat-
ible with all biochemical evidence.
We combined modeling with experiments to address these issues. Homology
modeling and MD simulations were used to determine the equilibrium confor-
mation of ATP-bound P-glycoprotein in a membrane environment. In contrast
to the conformations observed in crystal structures, the wing shape structure is
unstable in the membrane environment. The conformation observed by MD
simulations is devoid of the wing-shape, but in agreement with the bulk of
the biochemical data.
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The recently determined C. elegans P-glycoprotein (Pgp) structure revealed
significant deviations compared to the original mouse Pgp structure, which sug-
gested possible misinterpretations in the latter model. To address this concern,
we generated an experimental electron density map from single-wavelength
anomalous dispersion phasing of an original mouse Pgp dataset to 3.8 A˚ reso-
lution. The map was significantly improved in detail compared to the original
MAD map and revealed several regions of the structure that required de novo
model building. The improved drug-free structure was refined to 3.8 A˚ resolu-
tion with a 9.4% and 8.1% decrease in Rwork and Rfree, respectively
(Rwork=21.2%, Rfree=26.6%) and a significant improvement in protein geom-
etry. The improved mouse Pgp model contains ~ 95% of residues in the favor-
able Ramachandran region compared to only 57% for the original model. The
registry of six transmembrane helices was adjusted, revealing amino acid res-
idues involved in drug binding that were previously unrecognized. The greatest
changes required registry shifts (rotations and translations) for TM4 and TM5
as well as the addition of three N-terminal residues to the model - each vali-
dated with new mercury labeling and anomalous fourier density. The corrected
position of TM4, which forms the frame of a portal for drug entry, was shifted
> 6 A˚ from its original position. The drug translocation pathway of mouse Pgp
is 96% identical to human Pgp and is enriched in aromatic residues that likely
play a collective role in allowing a high degree of polyspecificity in substrate
recognition.
